choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Pacira Pharmaceuticals IPO

Pacira Pharmaceuticals IPO Newsletter
  • TELA Bio Starts $69 Million IPO Process 21 Oct 2019 21:05 GMT

    … Systems, Quaker Partners, OrbiMed, Pacira Pharmaceuticals, and Signet Healthcare Partners. … Listed underwriters of the IPO are Jefferies, Piper Jaffray … S. IPOs with IPO Edge research. Members of IPO Edge … get the latest IPO research, news …

  • Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer 05 Nov 2024 13:30 GMT

    … China. At Pacira Pharmaceuticals, Inc., he partnered on the company’s IPO, contributing …

  • Centrexion IPO: At Phase 3, But Don't Expect The Share Price To Go To The Moon 13 Nov 2018 18:45 GMT

    … in hand before the IPO seems sufficient to pay … these warrant liabilities after the IPO. The image below shows … million shares outstanding once the IPO goes live. At $15 … ; Co. (MRK) Novartis (NVS) Pacira Pharmaceuticals (PCRX) Pain Therapeutics (PTIE) Pfizer …

  • Liquidia IPO: Phase 3 Clinical Stage That Interested The Bill Gates Foundation 08 Aug 2018 16:04 GMT

    … shares outstanding after the IPO, the cash per share … good comparable peers of Liquidia. Pacira Pharmaceuticals, Inc. (PCRX) makes $ … investors prior to the IPO. The number of institutions … is somewhat usual in pharmaceutical IPOs, Liquidia’s partners are …

  • The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs 28 Jul 2018 18:18 GMT

    … See Also: Tricida Post-IPO Run-up Makes Goldman Wary … : RVNC) (after the close) Pacira Pharmaceuticals Inc (NASDAQ: PCRX) (before … Therapeutics Inc (NASDAQ: PETX) IPO Bionano Genomics, an instrumentation company … million shares in an IPO, with the price range …

  • PolyPid: Strong Pipeline, Close Catalysts 19 Apr 2022 19:07 GMT

    … systems, such as DepoFoam by Pacira Pharmaceuticals, Inc., ZYNRELEF by Heron Therapeutics … . Financials PolyPid closed its IPO on the Nasdaq on June … (for Q4 2020) since IPO was made on February 10 … , nearly the third of the IPO price ($323 million). Market …

  • Small-Stock Fund Managers Dominate the Battle for Highest Returns 10 Jul 2018 08:39 GMT

    … the opioid crisis. These include Pacira Pharmaceuticals , PCRX 1.03% which has … the team bought following an initial public offering. The company was bargain-priced …

Satisfied with the content?

Continue to create your account.